Growth Metrics

bioAffinity Technologies (BIAF) EPS (Weighted Average and Diluted) (2022 - 2025)

Historic EPS (Weighted Average and Diluted) for bioAffinity Technologies (BIAF) over the last 4 years, with Q3 2025 value amounting to -$4.74.

  • bioAffinity Technologies' EPS (Weighted Average and Diluted) rose 206.61% to -$4.74 in Q3 2025 from the same period last year, while for Sep 2025 it was $10.4, marking a year-over-year increase of 28943.53%. This contributed to the annual value of -$0.75 for FY2024, which is 1807.13% up from last year.
  • According to the latest figures from Q3 2025, bioAffinity Technologies' EPS (Weighted Average and Diluted) is -$4.74, which was up 206.61% from -$0.17 recorded in Q2 2025.
  • bioAffinity Technologies' EPS (Weighted Average and Diluted)'s 5-year high stood at $0.22 during Q4 2022, with a 5-year trough of -$4.84 in Q3 2024.
  • Over the past 4 years, bioAffinity Technologies' median EPS (Weighted Average and Diluted) value was -$0.2 (recorded in 2023), while the average stood at -$0.89.
  • In the last 5 years, bioAffinity Technologies' EPS (Weighted Average and Diluted) skyrocketed by 7777.78% in 2023 and then plummeted by 176153.85% in 2024.
  • Quarter analysis of 4 years shows bioAffinity Technologies' EPS (Weighted Average and Diluted) stood at $0.22 in 2022, then plummeted by 218.18% to -$0.26 in 2023, then increased by 5.89% to -$0.24 in 2024, then plummeted by 1837.13% to -$4.74 in 2025.
  • Its last three reported values are -$4.74 in Q3 2025, -$0.17 for Q2 2025, and -$0.16 during Q1 2025.